Sarah Carmody | Executive Director, Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Brian DeSchuytner | Senior Vice President-Finance and Product Strategy |
Tim Lowinger | Chief Science and Technology Officer |
Chuck Miller | Senior Vice President-Regulatory Affairs |
Jonathan Chang | SVB Leerink |
Boris Peaker | Cowen |
Tom Shrader | BTIG |
Daniel Wolle | J.P. Morgan |
Mike Ulz | Baird |
Good morning, and welcome to Mersana Therapeutics' Third Quarter 2020 Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. I would now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.